These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 17323383)

  • 1. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo.
    Pilorget A; Conesa M; Sarray S; Michaud-Levesque J; Daoud S; Kim KS; Demeule M; Marvaldi J; El Ayeb M; Marrakchi N; Béliveau R; Luis J
    J Cell Physiol; 2007 May; 211(2):307-15. PubMed ID: 17323383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lebectin and lebecetin, two C-type lectins from snake venom, inhibit alpha5beta1 and alphaV-containing integrins.
    Sarray S; Delamarre E; Marvaldi J; El Ayeb M; Marrakchi N; Luis J
    Matrix Biol; 2007 May; 26(4):306-13. PubMed ID: 17300927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIVL, a snake venom Kunitz-type serine protease inhibitor, inhibits in vitro and in vivo angiogenesis.
    Morjen M; Honoré S; Bazaa A; Abdelkafi-Koubaa Z; Ellafi A; Mabrouk K; Kovacic H; El Ayeb M; Marrakchi N; Luis J
    Microvasc Res; 2014 Sep; 95():149-56. PubMed ID: 25173589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.
    Shibata A; Nakagawa K; Sookwong P; Tsuzuki T; Oikawa S; Miyazawa T
    Biochem Pharmacol; 2008 Aug; 76(3):330-9. PubMed ID: 18599020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
    Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ
    Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic activity of beta-eudesmol in vitro and in vivo.
    Tsuneki H; Ma EL; Kobayashi S; Sekizaki N; Maekawa K; Sasaoka T; Wang MW; Kimura I
    Eur J Pharmacol; 2005 Apr; 512(2-3):105-15. PubMed ID: 15840394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lebectin, a novel C-type lectin from Macrovipera lebetina venom, inhibits integrin-mediated adhesion, migration and invasion of human tumour cells.
    Sarray S; Berthet V; Calvete JJ; Secchi J; Marvaldi J; El-Ayeb M; Marrakchi N; Luis J
    Lab Invest; 2004 May; 84(5):573-81. PubMed ID: 15048137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of an Anti-Tumour Disintegrin: Dabmaurin-1, a Peptide Lebein-1-Like, from
    Chalier F; Mugnier L; Tarbe M; Aboudou S; Villard C; Kovacic H; Gigmes D; Mansuelle P; de Pomyers H; Luis J; Mabrouk K
    Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32033352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A horsefly saliva antigen 5-like protein containing RTS motif is an angiogenesis inhibitor.
    Ma D; Gao L; An S; Song Y; Wu J; Xu X; Lai R
    Toxicon; 2010 Jan; 55(1):45-51. PubMed ID: 19635491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibronectin promotes brain capillary endothelial cell survival and proliferation through alpha5beta1 and alphavbeta3 integrins via MAP kinase signalling.
    Wang J; Milner R
    J Neurochem; 2006 Jan; 96(1):148-59. PubMed ID: 16269008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lebectin increases N-cadherin-mediated adhesion through PI3K/AKT pathway.
    Sarray S; Siret C; Lehmann M; Marrakchi N; Luis J; El Ayeb M; André F
    Cancer Lett; 2009 Nov; 285(2):174-81. PubMed ID: 19501458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel function of ascorbic acid as an angiostatic factor.
    Ashino H; Shimamura M; Nakajima H; Dombou M; Kawanaka S; Oikawa T; Iwaguchi T; Kawashima S
    Angiogenesis; 2003; 6(4):259-69. PubMed ID: 15166494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
    Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
    Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vixapatin (VP12), a c-type lectin-protein from Vipera xantina palestinae venom: characterization as a novel anti-angiogenic compound.
    Momic T; Cohen G; Reich R; Arlinghaus FT; Eble JA; Marcinkiewicz C; Lazarovici P
    Toxins (Basel); 2012 Oct; 4(10):862-77. PubMed ID: 23162702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypericin in the dark inhibits key steps of angiogenesis in vitro.
    Martínez-Poveda B; Quesada AR; Medina MA
    Eur J Pharmacol; 2005 Jun; 516(2):97-103. PubMed ID: 15921677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of recombinant RTS-jerdostatin on integrin α1β1 function during adhesion, migration and proliferation of rat aortic smooth muscle cells and angiogenesis.
    Bolás G; de Rezende FF; Lorente C; Sanz L; Eble JA; Calvete JJ
    Toxicon; 2014 Mar; 79():45-54. PubMed ID: 24418176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obtustatin: a potent selective inhibitor of alpha1beta1 integrin in vitro and angiogenesis in vivo.
    Marcinkiewicz C; Weinreb PH; Calvete JJ; Kisiel DG; Mousa SA; Tuszynski GP; Lobb RR
    Cancer Res; 2003 May; 63(9):2020-3. PubMed ID: 12727812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MVL-PLA2, a phospholipase A2 from Macrovipera lebetina transmediterranea venom, inhibits tumor cells adhesion and migration.
    Bazaa A; Luis J; Srairi-Abid N; Kallech-Ziri O; Kessentini-Zouari R; Defilles C; Lissitzky JC; El Ayeb M; Marrakchi N
    Matrix Biol; 2009 May; 28(4):188-93. PubMed ID: 19351557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.
    Mannell H; Hellwig N; Gloe T; Plank C; Sohn HY; Groesser L; Walzog B; Pohl U; Krotz F
    J Vasc Res; 2008; 45(2):153-63. PubMed ID: 17962719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-angiogenic properties of calcium trifluoroacetate.
    Bussolati B; Ribatti D; Munaron L; Bartorelli A; Bussolati G
    Microvasc Res; 2009 Dec; 78(3):272-7. PubMed ID: 19631669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.